Role of antimicrobial peptide on cariogenic biofilm and dental enamel demineralization
DOI:
https://doi.org/10.4322/bds.2024.e4263Abstract
Objective: To investigate the effect of antimicrobial peptide (AMP) D1-23 on antibiofilm activity and enamel demineralization by using a microcosm biofilm model. Material and Methods: Human saliva biofilm was grown on bovine enamel discs, which were divided into 4 groups according to the 24-hour growth treatment: 0.2 mM AMP D1-23; 1 mM AMP D1-23; Defined Medium with Mucin (DMM; negative control); and 2% chlorhexidine (CHX; positive control). The biomass and number of cultivable cells of a 4-day-old biofilm were evaluated for antibiofilm activity. For analysis of enamel mineral loss by the 7-day-old biofilm and investigated treatments, the Knoop surface microhardness method was performed. ANOVA and Tukey tests were used to analyze data from biomass and enamel surface microhardness. Culturable cells data were analyzed by a pairwise Kruskal-Wallis test. A significance level of 5% was considered for all tests. Results: Although the two concentrations of AMP D1-23 had similar effects on the amount of biofilm biomass (p>0.05), a reduction in biomass was observed when compared to the control group (p < 0.05). The antimicrobial activity of 1 mM AMP D1-23 was similar to that of 2% CHX against Streptococcus mutans, whereas against Streptococci sp and Candida sp it was lower (p <0.05). Also, the 1 mM AMP D1-23 significantly reduced enamel demineralization (p < 0.05). Conclusion: Under the limitations of this study, the 1 mM AMP D1-23 appears to have positive effect on controlling dental enamel demineralization and may be considered a potential treatment for non-cavitated carious lesions.
KEYWORDS
Antimicrobial cationic peptides; Dental caries, Dental plaque; Public health; Tooth remineralization.
Downloads
Published
How to Cite
Issue
Section
License
Brazilian Dental Science uses the Creative Commons (CC-BY 4.0) license, thus preserving the integrity of articles in an open access environment. The journal allows the author to retain publishing rights without restrictions.
=================
COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
(PDF)
For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.
Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).
The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.
This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.
